As South Africa continues to navigate a complex economic environment, new insights from the SAB Foundation offer a grounded view of how small businesses are adapting, building resilience, and creating ...

Pakistan Muslim League Nawaz (PML-N) President Nawaz Sharif on Sunday visited the holy shrine of Sufi saint Hazrat Ali Bin Usman Hajveri (Data Darbar) to review the renovation and expansion of the the ...

Nawaz Sharif visited Data Darbar to oversee renovation and expansion efforts, emphasizing the importance of enhancing facilities for millions of devotees. The project aims to preserve the shrine's ...

LAHORE: Three officials of the contractor working on the project were arrested on Thursday in the wake of the death of a young mother and her minor daughter after their fall into an open manhole of ...

LAHORE: “All development work at Data Darbar shrine must be completed within the stipulated time,” said Secretary Auqaf Punjab Dr Ehsan Bhutta during his visit to the Data Darbar shrine and its ...

LAHORE: Punjab Housing Minister Bilal Yasin has said that the number of tourists and devotees is expected to increase significantly after the completion of the Data Darbar and Bhati Chowk Expansion ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed healthy volunteers Study results support the chronic dosing ...

MIAMI, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes ...

LAHORE: The Data Darbar expansion project was formally launched on Friday. The project aims to provide modern facilities at the Data Darbar for visitors, while preserving the spiritual heritage of the ...

A man was injured in shooting incident triggered by a monetary dispute in the Data Darbar area. According to officials, the incident took place on Mohni Road near Bilal Ganj, where Toofan Khan, ...

MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes ...